Back

Trefoil factor 3 positively associates with IL-25 in patients with Chronic Rhinosinusitis

Ortiz-Carpena, J. F.; Maina, I. W.; Lin, C.; Patel, N. N.; Triantafillou, V.; Luu, N. N.; Kohanski, M. A.; Kuan, E. C.; Tong, C. C. L.; Bosso, J. V.; Adappa, N. D.; Palmer, J. N.; Reed, D. R.; Herbert, D. R.; Cohen, N. A.

2020-06-23 allergy and immunology
10.1101/2020.06.21.20136861
Show abstract

BackgroundTrefoil factor family cytokines (TFF1-3) have documented reparative and immunoregulatory effects on mucosal epithelial cells that include: blocking apoptosis, directed cell migration, and regulation of pro-inflammatory cytokine production. TFF1 and TFF3 have been shown to undergo altered expression within sinonasal tissues of patients with various forms of chronic rhinosinusitis including those with or wthout polyp associated disease, but the cellular source(s) of TFF members in CRS remains unclear. To further explore the role of TFF3 in inflammatory sinonasal disease, we sought to determine its expression pattern in immune and non-immune cell types in CRS disease. MethodsPolyp and inferior turbinate tissues were isolated from patients undergoing surgical resection for treatment of CRS. Tissue homogenates and single cell suspensions were subjected to enzyme linked immunosorbent assay (ELISA) and single-cell RNA sequencing. Air liquid interface cultures of sinonasal epithelia were subjected to immunofluorescence (IF) microscopy. Interleukin 25, TFF2 and TFF3 protein levels were compared to sinonasal outcome test scores (SNOT-22) to determine whether levels associated with post-operative outcomes. ResultsTFF3 was broadly expressed in goblet cells, ciliated cells, Tuft cells and T lymphocytes. TFF3 protein levels positively associated with IL-25 in CRSwNP patients. Lastly, TFF3 protein levels positively associated with clinical improvement post-surgery. ConclusionsTFF3 is broadly expressed within multiple epithelial and immune cell lineages in patients with CRSwNP. Protein levels of TFF3 correlate with IL-25 and clinical signs of disease, however TFF3 levels associate with clinical improvement following surgical intervention indicating a potential beneficial role for this reparative cytokine in CRS patients.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of Experimental Medicine
based on 10 papers
Top 0.1%
10.1%
2
Clinical Immunology
based on 12 papers
Top 0.1%
7.5%
3
Clinical Infectious Diseases
based on 219 papers
Top 4%
6.3%
4
PLOS ONE
based on 1737 papers
Top 63%
6.3%
5
Nature Immunology
based on 14 papers
Top 0.1%
5.3%
6
Frontiers in Immunology
based on 140 papers
Top 1%
5.0%
7
European Respiratory Journal
based on 44 papers
Top 1%
4.4%
8
Journal of Allergy and Clinical Immunology
based on 15 papers
Top 0.3%
4.4%
9
Allergy
based on 13 papers
Top 0.5%
4.4%
50% of probability mass above
10
JCI Insight
based on 63 papers
Top 2%
2.8%
11
mSphere
based on 27 papers
Top 0.3%
2.8%
12
The Journal of Infectious Diseases
based on 137 papers
Top 3%
2.8%
13
Journal of Medical Virology
based on 95 papers
Top 4%
2.4%
14
The Journal of Immunology
based on 19 papers
Top 0.8%
2.3%
15
Journal of Clinical Investigation
based on 50 papers
Top 1%
2.3%
16
Science Immunology
based on 15 papers
Top 0.7%
1.6%
17
Scientific Reports
based on 701 papers
Top 78%
1.3%
18
Thorax
based on 29 papers
Top 2%
1.3%
19
British Journal of Anaesthesia
based on 13 papers
Top 2%
1.3%
20
EBioMedicine
based on 21 papers
Top 0.7%
1.3%
21
iScience
based on 74 papers
Top 6%
1.2%
22
Journal of Clinical Immunology
based on 11 papers
Top 0.5%
1.2%
23
Journal of Clinical Pathology
based on 11 papers
Top 0.8%
1.2%
24
Annals of the Rheumatic Diseases
based on 23 papers
Top 1.0%
1.2%
25
Journal of Cystic Fibrosis
based on 10 papers
Top 1.0%
0.8%
26
Cells
based on 14 papers
Top 2%
0.7%
27
Cell Genomics
based on 34 papers
Top 5%
0.7%
28
Cell Reports Medicine
based on 49 papers
Top 6%
0.7%
29
Respiratory Research
based on 10 papers
Top 2%
0.7%
30
Pediatric Research
based on 15 papers
Top 2%
0.7%